We found that diabetes comorbidity and corticosteroids therapy, as well as the SpO2, CRP, PCT, and fibrinogen levels, affect the prolonged production of NAbs against SARS-CoV-2 in individuals who recover from COVID-19. The gene discussed is CRP; the disease is COVID-19.